CEL-SCI Corp. (CVM)
1.48
0.00 (0.00%)
USD |
NYAM |
Sep 16, 16:00
1.495
+0.02
(+1.01%)
After-Hours: 20:00
CEL-SCI Price : 1.48 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 1.496 | 1.53 | 1.47 | 1.48 | 72610.00 |
| Sep 15, 2026 | 1.53 | 1.54 | 1.47 | 1.48 | 95497.00 |
| Sep 14, 2026 | 1.46 | 1.56 | 1.46 | 1.52 | 66535.00 |
| Sep 11, 2026 | 1.55 | 1.55 | 1.46 | 1.49 | 98522.00 |
| Sep 10, 2026 | 1.57 | 1.58 | 1.51 | 1.52 | 75964.00 |
| Sep 09, 2026 | 1.67 | 1.67 | 1.54 | 1.54 | 85822.00 |
| Sep 08, 2026 | 1.64 | 1.765 | 1.64 | 1.65 | 283876.0 |
| Sep 04, 2026 | 1.61 | 1.63 | 1.58 | 1.63 | 75071.00 |
| Sep 03, 2026 | 1.65 | 1.679 | 1.604 | 1.61 | 117061.0 |
| Sep 02, 2026 | 1.64 | 1.701 | 1.60 | 1.65 | 134713.0 |
| Sep 01, 2026 | 1.60 | 1.631 | 1.565 | 1.61 | 70256.00 |
| Aug 31, 2026 | 1.59 | 1.62 | 1.54 | 1.62 | 56390.00 |
| Aug 28, 2026 | 1.61 | 1.61 | 1.525 | 1.56 | 170340.0 |
| Aug 27, 2026 | 1.60 | 1.69 | 1.565 | 1.60 | 161623.0 |
| Aug 26, 2026 | 1.55 | 1.70 | 1.525 | 1.61 | 263050.0 |
| Aug 25, 2026 | 1.40 | 1.500 | 1.370 | 1.48 | 86443.00 |
| Aug 24, 2026 | 1.42 | 1.43 | 1.34 | 1.38 | 149139.0 |
| Aug 21, 2026 | 1.48 | 1.49 | 1.42 | 1.42 | 66143.00 |
| Aug 20, 2026 | 1.62 | 1.64 | 1.45 | 1.46 | 183496.0 |
| Aug 19, 2026 | 1.61 | 1.69 | 1.59 | 1.64 | 184790.0 |
| Aug 18, 2026 | 1.57 | 1.675 | 1.55 | 1.59 | 228789.0 |
| Aug 17, 2026 | 1.60 | 1.625 | 1.45 | 1.55 | 129424.0 |
| Aug 14, 2026 | 1.52 | 1.64 | 1.520 | 1.54 | 218400.0 |
| Aug 13, 2026 | 1.48 | 1.49 | 1.45 | 1.49 | 57197.00 |
| Aug 12, 2026 | 1.51 | 1.54 | 1.45 | 1.48 | 152982.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.21 |
| Amgen, Inc. | 376.35 |
| Anika Therapeutics, Inc. | 20.84 |
| BioCryst Pharmaceuticals, Inc. | 8.43 |
| Imunon, Inc. | 1.41 |
Price Related Metrics
| Price to Book Value | 2.376 |
| Earnings Yield | -174.5% |
| Market Cap | 26.03M |